Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk

C Borghi, A Tykarski, K Widecka, KJ Filipiak… - Cardiology …, 2018 - journals.viamedica.pl
The definition of hyperuricemia (HU) varies widely in different studies, which makes the
epidemiological reports somewhat inconsistent. HU remains the culprit of the pathogenesis …

Mechanisms and rationale for uricase use in patients with gout

N Schlesinger, F Pérez-Ruiz, F Lioté - Nature Reviews Rheumatology, 2023 - nature.com
Xanthine oxidase inhibitors such as allopurinol and febuxostat have been the mainstay
urate-lowering therapy (ULT) for treating hyperuricaemia in patients with gout. However, not …

Gout and hyperuricaemia in the USA: prevalence and trends

G Singh, B Lingala, A Mithal - Rheumatology, 2019 - academic.oup.com
Objectives Several recent observations have suggested that the prevalence of gout may be
increasing worldwide, but there are no recent data from the USA. We analysed the …

Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: the URRAH (Uric Acid Right for Heart Health) study

E Casiglia, V Tikhonoff, A Virdis, S Masi… - Journal of …, 2020 - journals.lww.com
Objective: The Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of
Hypertension conceived and designed an ad-hoc study aimed at searching for prognostic …

Rethinking chronic kidney disease in the aging population

G Alfano, R Perrone, F Fontana, G Ligabue… - Life, 2022 - mdpi.com
The process of aging population will inevitably increase age-related comorbidities including
chronic kidney disease (CKD). In light of this demographic transition, the lack of an age …

Консенсус по ведению пациентов с гиперурикемией и высоким сердечно-сосудистым риском

ИЕ Чазова, ЮВ Жернакова, ОА Кисляк… - Системные …, 2019 - cyberleninka.ru
Значительное количество эпидемиологических исследований продемонстрировало,
что гиперурикемия в высокой степени связана с риском развития сердечно-сосудистых …

Wearable biosensors for human fatigue diagnosis: A review

J Zhang, M Chen, Y Peng, S Li, D Han… - Bioengineering & …, 2023 - Wiley Online Library
Fatigue causes deleterious effects to physical and mental health of human being and may
cause loss of lives. Therefore, the adverse effects of fatigue on individuals and the society …

Natural products and extracts as xantine oxidase inhibitors-a hope for gout disease?

IE Orhan, FSS Deniz - Current Pharmaceutical Design, 2021 - ingentaconnect.com
Xanthine oxidase (EC 1.17. 3.2)(XO) is one of the main enzymatic sources that create
reactive oxygen species (ROS) in the living system. It is a dehydrogenase enzyme that …

Characteristics, comorbidities, and potential consequences of uncontrolled gout: an insurance-claims database study

M Francis-Sedlak, B LaMoreaux… - Rheumatology and …, 2021 - Springer
Introduction Gout is a common, progressive, systemic inflammatory arthritis caused by
hyperuricemia. Current guidelines recommend that serum uric acid (sUA) levels be …

[HTML][HTML] Pegloticase treatment of chronic refractory gout: Update on efficacy and safety

N Schlesinger, PE Lipsky - Seminars in arthritis and rheumatism, 2020 - Elsevier
Gout is currently the most frequent cause of inflammatory arthritis worldwide. It results from
elevated serum urate and subsequent deposition of monosodium urate crystals in joints and …